NCT06089356招募中4 期
Zolmitriptane as Prophylactic Therapy Childhood Migraine
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- number and severity of migraine attacks
研究概览
简要总结
zolmitriptane can be tried as prophylactic therapy of childhood migraine
详细描述
90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 8 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •children with migraine -
排除标准
- •those who suffer from ischemic heart disease , or who have allergy to any of drugs used
研究组 & 干预措施
zolmitriptane
Active Comparator
zolmitriptane tablet daily
干预措施: zolmitriptanee (Drug)
topiramate
Active Comparator
topiramate tablet daily
干预措施: topiramate (Drug)
valproate
Active Comparator
valproate once daily
干预措施: Valproate (Drug)
结局指标
主要结局
number and severity of migraine attacks
时间窗: 6 months
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
professor
Tanta University
研究点 (1)
Loading locations...
相似试验
终止
3 期
The Childhood and Adolescent Migraine Prevention StudyMigraineMigraine DisordersHeadacheNCT01581281Children's Hospital Medical Center, Cincinnati488
已完成
不适用
A Study of Prophylaxis for Migraine Patients With Topiramate in IndiaMigraineNCT01836874Janssen-Cilag Ltd.209
终止
3 期
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineMigraineNCT04396236Eli Lilly and Company847
终止
4 期
Therapy for Migraine Prevention in Children 6-11 Years of AgeMigraine DisordersHeadache DisordersNCT04050293Supernus Pharmaceuticals, Inc.26
已完成
不适用
Cinnarizine in the prophylactic treatment of childhood migraine: a comparison with propranololHeadache severity recorded on a three scale,and was defined as mild (no effect on daily activities),moderate (disrupts daily activities),severe (requiring immediate intervention and treatment). Furchildrenheadachecinnarizinepropranololclinical trialmigraineTCTR20180903005Hormozgan University of Medical Sciences56